Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jeng

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Virology|November 10, 2017
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral TreatmentAmy L Ellis-Connell, Alexis J Balgeman, Katie R Zarbock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2022
Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cellsPallavi Chaturvedi, Varghese George, Niraj Shrestha, et al.
Cancer Research|March 17, 2016
IL15 Agonists Overcome the Immunosuppressive Effects of MEK InhibitorsMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
JCI Insight|December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus controlAnnelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Cancer Immunology Research|October 30, 2015
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal ModelsPeter R Rhode, Jack O Egan, Wenxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2021
Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8<sup>+</sup> T cell immunity against solid tumorsBai Liu, Xiaoyun Zhu, Lin Kong, et al.
Blood Advances|January 25, 2018
The human IL-15 superagonist ALT-803 directs SIV-specific CD8<sup>+</sup> T cells into B-cell folliclesGabriela M Webb, Shengbin Li, Gwantwa Mwakalundwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell LymphomasMaximillian Rosario, Bai Liu, Lin Kong, et al.
Plos Pathogens|April 16, 2016
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-LymphocytesR Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Virology|November 10, 2017
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral TreatmentAmy L Ellis-Connell, Alexis J Balgeman, Katie R Zarbock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2022
Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cellsPallavi Chaturvedi, Varghese George, Niraj Shrestha, et al.
Cancer Research|March 17, 2016
IL15 Agonists Overcome the Immunosuppressive Effects of MEK InhibitorsMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
JCI Insight|December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus controlAnnelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Cancer Immunology Research|October 30, 2015
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal ModelsPeter R Rhode, Jack O Egan, Wenxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2021
Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8<sup>+</sup> T cell immunity against solid tumorsBai Liu, Xiaoyun Zhu, Lin Kong, et al.
Blood Advances|January 25, 2018
The human IL-15 superagonist ALT-803 directs SIV-specific CD8<sup>+</sup> T cells into B-cell folliclesGabriela M Webb, Shengbin Li, Gwantwa Mwakalundwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell LymphomasMaximillian Rosario, Bai Liu, Lin Kong, et al.
Plos Pathogens|April 16, 2016
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-LymphocytesR Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.
Pageof 4